Situationsgerechte Anpassung der Diabetestherapie im Alter – State of the Art

Eine Insulintherapie wird früher oder später zur Kontrolle des Blutzuckers bei fast jedem Typ-2-Diabetiker erforderlich. In der Regel wird diese Therapie im Lauf der Zeit komplexer, die Zahl der Injektionen steigt. Mit zunehmendem Alter und steigender Immobilität kann jedoch eine Rückführung zu einer weniger flexiblen, aber dafür einfacheren Insulintherapie sinnvoll sein.

An insulin therapy to manage blood glucose levels will become necessary at some time or another for practically every patient with type 2 diabetes. As a general rule such a therapy becomes increasingly complex with time, and the number of injections increases. With increasing age and decreasing mobility it may be meaningful to go back to a less flexible but accordingly simpler insulin therapy.

Key words

type-2 diabetes - insulin therapy - advanced age - immobility - adaptation of insulin therapy

• Literatur

• 1 IDF-Atlas 2011. http://www.idf.org/media-events/press-releases/2011/diabetes-atlas-5th-edition
• 2 Zeyfang A et al. Diabetes mellitus im Alter. Diabetologie 2011; 6: 170-175
• 3 Lasserson DS et al. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia 2009; 52: 1990-2000
• 4 Crenier L et al. An observational efficacy study of elderly patients with T2D switching from biphasic human insulin to biphasic insulin aspart 30/50/70. IDF 2011 Dubai World Diabetes Congress Abstract: P. 1136-1136
• 5 Malone JK et al. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy. Clin Ther Erratum in: Clin Ther 2005; 27: 1112-1112
• 6 Garber AJ et al. premixed insulin treatment for type 2 diabetes: analogue or human?. Diabetes Obes Metab 2007; 9: 630-639
• 7 Quayyum R et al. Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes. Ann Intern Med 2008; 149: 549-559
• 8 Perez N et al. Initiation of insulin therapy in elderly patients taking oral antidiabetes drugs. CMAJ 2009; 180: 1310-1316
• 9 Yang W et al. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs. Diabetes Care 2008; 31: 852-856
• 10 Rolla AR et al. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues. Clin Ther 2005; 27: 1113-1125
• 11 Raccah D et al. When basal insulin therapy in type 2 diabetes mellitus is not enough - what next?. Diabetes Metab Res Rev 2007; 23: 257-264
• 12 Giugliano D et al. Efficacy of insulin analogs in achieving the hemoglobin A1c target of < 7 % in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Care 2011; 34: 510-517
• 13 Miser WF et al. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial. Clin Ther 2010; 32: 896-908
• 14 Buse JB. The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargine. Diabetes Care 2011; 34: 249-255
• 15 Unnikrishnan AG et al. Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement. Int J Clin Pract 2009; 63: 1571-1577